Texas Permanent School Fund’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,338
Closed -$265K 1545
2023
Q1
$265K Buy
9,338
+2,422
+35% +$68.7K ﹤0.01% 1500
2022
Q4
$202K Sell
6,916
-732
-10% -$21.4K ﹤0.01% 1492
2022
Q3
$202K Sell
7,648
-452
-6% -$11.9K ﹤0.01% 1483
2022
Q2
$360K Buy
8,100
+43
+0.5% +$1.91K 0.01% 1426
2022
Q1
$399K Sell
8,057
-135
-2% -$6.69K 0.01% 1435
2021
Q4
$417K Sell
8,192
-334
-4% -$17K 0.01% 1447
2021
Q3
$476K Sell
8,526
-169
-2% -$9.44K 0.01% 1424
2021
Q2
$372K Buy
8,695
+31
+0.4% +$1.33K ﹤0.01% 1463
2021
Q1
$362K Sell
8,664
-648
-7% -$27.1K ﹤0.01% 1456
2020
Q4
$434K Sell
9,312
-1,992
-18% -$92.8K 0.01% 1406
2020
Q3
$480K Buy
11,304
+3,303
+41% +$140K 0.01% 1346
2020
Q2
$384K Sell
8,001
-526
-6% -$25.2K 0.01% 1349
2020
Q1
$392K Buy
8,527
+1,607
+23% +$73.9K 0.01% 1295
2019
Q4
$416K Buy
6,920
+36
+0.5% +$2.16K 0.01% 1371
2019
Q3
$389K Sell
6,884
-109
-2% -$6.16K 0.01% 1374
2019
Q2
$389K Sell
6,993
-3
-0% -$167 0.01% 1376
2019
Q1
$353K Sell
6,996
-201
-3% -$10.1K 0.01% 1402
2018
Q4
$290K Buy
7,197
+187
+3% +$7.54K 0.01% 1406
2018
Q3
$486K Buy
7,010
+1,638
+30% +$114K 0.01% 1345
2018
Q2
$406K Sell
5,372
-160
-3% -$12.1K 0.01% 1398
2018
Q1
$291K Sell
5,532
-117
-2% -$6.16K ﹤0.01% 1450
2017
Q4
$302K Sell
5,649
-576
-9% -$30.8K ﹤0.01% 1442
2017
Q3
$371K Buy
6,225
+529
+9% +$31.5K ﹤0.01% 1419
2017
Q2
$449K Sell
5,696
-171
-3% -$13.5K 0.01% 1369
2017
Q1
$487K Buy
5,867
+125
+2% +$10.4K 0.01% 1332
2016
Q4
$456K Sell
5,742
-333
-5% -$26.4K 0.01% 1357
2016
Q3
$425K Buy
+6,075
New +$425K 0.01% 1355